Levels of lipids and apolipoproteins in three cultures

Atherosclerosis

Volumn 207, Issue 1, 2009, Pages 200-207

  Solhpour, Amirreza ^a   Parkhideh, Sahar ^a   Sarrafzadegan, Nizal ^b   Asgary, Sedigheh ^b   Williams, Ken ^c   Jungner, Ingmar ^d   Aastveit, Are ^e   Walldius, Göran ^d   Sniderman, Allan ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KenAnCo Biostatistics   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

^e NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

Author keywords

Apolipoproteins; Cultures; Lipids; Risk; Vascular Disease

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANALYTIC METHOD; ARTICLE; ASIAN; CONTROLLED STUDY; CULTURAL ANTHROPOLOGY; FEMALE; HUMAN; IRAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE DIFFERENCE; SEX DIFFERENCE; SWEDEN; UNITED STATES;

ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-CULTURAL COMPARISON; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IRAN; LIPIDS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEX DISTRIBUTION; SEX FACTORS; SWEDEN; TIME FACTORS; TRIGLYCERIDES; UNITED STATES; YOUNG ADULT;

EID: 70350568160     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.09.003     Document Type: Article

References (24)

1. Yusuf S., Hawken S., Ounpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004) 937-952
2. Barter P.J., Ballantyne C.M., Carmena R., et al. ApoB versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. J Intern Med 259 (2006) 247-258
3. Marcovina S.M., Gaur V.P., and Albers J.J. Biological variability of cholesterol, triglyceride, low- and high-density lipoprotein cholesterol, lipoprotein (a), and apolipoproteins A-I and B. Clin Chem 40 (1994) 574-578
4. McQueen M.J., Hawken S., Wang X., et al. The relative importance of lipids, lipoproteins, and apolipoproteins as risk markers associated with myocardial infarction in 52 countries. Lancet 372 (2008) 224-233
5. Walldius G., Jungner I., Holme I., Aastveit A.H., Kolar W., and Steiner E. High apolipoprotein B, low apolipoprotein A-1, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 358 (2001) 2026-2033
6. Karthikeyan G., Koon K.T., Islam S., et al. Lipid profile, plasma apolipoproteins, and risk of a first myocardial infarction among Asians. J Am Coll Cardiol 53 (2009) 244-253
7. Sarrafzadegan N., Sadri G., Malek A.H., et al. Isfahan Healthy Heart Programme: a comprehensive integrated community-based programme for cardiovascular disease prevention and control. Design, methods and initial experience. Acta Cardiol 58 (2003) 309-320
8. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
9. Riepponen P., Marniemi J., and Rautaoja T. Immunoturbidimetric determination of apolipoproteins A-1 and B in serum. Scand J Clin Lab Invest 47 (1987) 739-744
10. http://www.cdc.gov/nchs/nhanes/nh3data.htm. Accessed May 30, 2008.
11. Harrell F.E. Regression Modeling Strategies with Applications to Linear Models. Logistic Regression and Survival Analysis (2001), Springer, New York p. 206
12. Jungner I., Marcovina S.M., Walldius G., Holme I., Kolar W., and Steiner E. Apolipoprotein B and A-I values in 147,576 Swedish males and females, standardized according to the World Health Organization-International Federation of Clinical Chemistry First International Reference Materials. Clin Chem 44 (1998) 1641-1649
13. Levy D., and Kannel W.B. Searching for answers to ethnic disparities in cardiovascular risk. Lancet 356 (2000) 266-267
14. Sarrafzadegan N., Sayed-Tabatabaei F.A., Bashardoost N., et al. The prevalence of coronary artery disease in an urban population in Isfahan. Iran Acta Cardiol 54 (1999) 257-264
15. Hadaegh F., Harati H., Ghanbarian A., and Azizi F. Prevalence of coronary heart disease among Tehran adults: Tehran Lipid and Glucose Study. East Mediterr Health J 15 (2009) 157-166
16. Ghoddusi K., Ameli J., Kachuee H., Pourfarziani V., Saadat A., and Karami Q. Association of diabetes meelitus and dyslipidaemias in the Tehran population. East Mediterr Health J 14 (2008) 647-653
17. Wilhelmsen L., Johansson S., Rosengren A., Wallin I., Dotevall A., and Lappas G. Risk factors for cardiovascular disease during the period 1985-1995 in Goteborg. Sweden. The GOT-MONICA Project. J Intern Med 242 (1997) 199-211
18. Nilsson G, Ohrvik J, Lonnberg I, Hedberg P. Ten-year survival in 75-year-old men and women: predictive ability of total cholesterol, HDL-C and LDL-C. Curr Gerontol Geriatr Res 2009,1-7 (article ID 158425).
19. Berg C.M., Lissner L., Aires N., et al. Trends in blood lipid levels, blood pressure, alcohol and smoking habits from 1985 to 2002: results from INTERGENE and GOT-MONICA. Eur J Cardiovasc Prev Rehabil 12 (2005) 115-125
20. Sniderman A.D., Zhang X.J., and Cianflone K. Governance of the concentration of plasma LDL: a re-evaluation of the LDL receptor paradigm. Atherosclerosis 148 (2000) 215-229
21. Knuiman J.T., West C.E., Katan M.B., and Hautvast J.G. Total cholesterol and high-density lipoprotein cholesterol levels in populations differing in fat and carbohydrate intake. Arteriosclerosis 7 (1987) 612-619
22. Tremblay A.J., Sniderman A.D., Gagne C., Bergeron J., and Couture P. Differential impact of plasma triglycerides on HDL-cholesterol and HDL-apo A-1 in a large cohort. Clin Biochem 40 (2007) 25-29
23. Sarrafzadegan N., Kelishadi R., Baghaei A., et al. Metabolic syndrome: An emerging public health problem in Iranian women: Isfahan Healthy Heart Program. Int J Cardiol (2008) 90-96
24. de Graaf J., Couture P., and Sniderman A. A diagnostic algorithm for the atherogenic apolipoprotein B dyslipoproteinemias. Nature Clin Endocrinol Metab 4 (2008) 608-618